Different classical pathological markers was used to conform patients clinical character like tumor size, as well as estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) statuses. This evidence concerns the gene ERBB2 and neoplasm.